SCHEMBL22470204

SCHEMBL22470204

CN(CCCC(=O)NO)CCNC(=O)c1cccc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 12/20 0.54
HDAC2 Q92769 11/20 0.54
HDAC6 Q9UBN7 8/20 0.54
HDAC8 Q9BY41 7/20 0.54
HDAC3 O15379 7/20 0.54
HDAC4 P56524 6/20 0.54
HDAC7 Q8WUI4 6/20 0.54
HDAC10 Q969S8 6/20 0.54
HDAC11 Q96DB2 6/20 0.54
HDAC9 Q9UKV0 6/20 0.54
HDAC5 Q9UQL6 6/20 0.54
PPARG P37231 1/20 0.51
MMP3 P08254 1/20 0.49
HPGD P15428 1/20 0.48
RAD52 P43351 1/20 0.47
PLK1 P53350 1/20 0.45
ALDH1A1 P00352 1/20 0.45
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22470295 0.85 HDAC1 (0.47) HDAC1HDAC2HDAC6HDAC8HDAC3
SCHEMBL22470210 0.84 SIGMAR1 (0.61) HDAC1HDAC2HDAC6HDAC8HDAC3
SCHEMBL22470227 0.84 NAAA (0.51) HDAC1HDAC2HDAC6HDAC8HDAC3
SCHEMBL29356487 0.84 HDAC1 (0.47) HDAC1HDAC2HDAC6HDAC8HDAC3
SCHEMBL22470200 0.84 HDAC1 (0.47) HDAC1HDAC2HDAC6HDAC8HDAC3
SCHEMBL1233412 0.83 HDAC1 (0.67) HDAC1HDAC2HDAC6HDAC8HDAC3
SCHEMBL22470283 0.82 ALDH1A1 (0.50) HDAC1HDAC2HDAC6HDAC8HDAC3
SCHEMBL22470277 0.82 HDAC1 (0.56) HDAC1HDAC2HDAC6HDAC8HDAC3
SCHEMBL22439790 0.80 HDAC6 (0.66) HDAC1HDAC2HDAC6HDAC8HDAC3
SCHEMBL4371080 0.80 RAD52 (0.67) HDAC1HDAC2HDAC6HDAC8HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220151962-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2022-05-19 US disclosed
US-20220151962-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2022-05-19 US disclosed
EP-3941900-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 Deutsches Krebsforschungszentrum (DE) 2022-01-26 EP disclosed
WO-2020193431-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2020-10-01 WO disclosed
WO-2020193431-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2020-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220151962-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 HDAC10, HDAC1, HDAC11 HDAC1 2/4885HDAC2 6/4885HDAC6 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.